Phase I Studies: On Time with Quality Data

July 24, 2024

Consistent Early Phase Milestone Achievement

Backed by select partnerships with Phase I Specialty Units and a tenured team, CRC consistently reaches milestones under tight clinical timelines in early phase studies. Learn how our strategic approach and robust collaboration led to dosing the last subject two weeks ahead of schedule while maintaining data quality in the case study below.

< Older Post

Newer Post >
Dementia patient and doctor in clinical setting related to agitation trial

Mastering Agitation Endpoints with Assessment Expertise

July 30, 2025
Discover how CRC managed rater complexity and timelines in an agitation study using customized training and algorithmic oversight.
Alzheimer's patient with doctor

Seamless Execution Across Early-Phase Alzheimer’s Trials

July 15, 2025
Discover how CRC supported a novel Alzheimer’s program through first-in-human (FIH), Phase Ib/IIa, and OLE trials with precision, urgency, and trusted oversight.
Illustration of active brain neurons highlighting neural pathways

The Expanding Role of GLP-1 Receptor Agonists in CNS Clinical Research

July 1, 2025
GLP-1 receptor agonists may offer a new path for treating addiction and mental health challenges, emerging as a versatile class in CNS clinical research.
Show More